Skip to main content
Susan King, MD, Otolaryngology (ENT), San Antonio, TX, Methodist Hospital

SusanMarendaKingMD

Otolaryngology (ENT) San Antonio, TX

Neurotology

Physician

Dr. King is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. King's full profile

Already have an account?

Education & Training

  • Texas Neuroscience Institute
    Texas Neuroscience InstituteFellowship, Neurotology, 1995 - 1996
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Otolaryngology - Head and Neck Surgery, 1990 - 1994
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Otolaryngology - Head and Neck Surgery, 1989 - 1990
  • Creighton University School of Medicine
    Creighton University School of MedicineClass of 1989

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1990 - 2024
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • American Board of Otolaryngology - Head and Neck Surgery Neurotology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2014
  • Super Doctor SuperDoctors.com
  • Fellow (FACS) American College of Surgeons
  • Join now to see all

Publications & Presentations

PubMed

Other

  • Phase 1/2 trial 
    King
    New Orleans

Press Mentions

  • Frequency Therapeutics Announces Positive Phase 1/2 Data for Drug Candidate for Hearing Restoration
    Frequency Therapeutics Announces Positive Phase 1/2 Data for Drug Candidate for Hearing RestorationApril 9th, 2019

Professional Memberships

Hospital Affiliations